QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 06/21/2018 -- This report studies the global Paclitaxel industry status, China market entry and growth opportunity, focuses on the Chinese local and International manufacturers, analyzes the China market competition landscape, market size (value and volume), opportunity and challenge, risk and entry barriers.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/524798/global-paclitaxel-industry-research-china-market
Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel is sales in Ovarian Cancer, and the consumption proportion is about 46% in 2017.
North America is the largest consumption place, with a consumption market share nearly 52.3% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 19.6%, China is also an important sales regions for the Paclitaxel.
The global Paclitaxel market is valued at 79 million USD in 2017 and is expected to reach 160 million USD by the end of 2025, growing at a CAGR of 9.4% between 2018 and 2025.
This research report categorizes the China and global Paclitaxel market by type, end-use industry, and region.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/524798/global-paclitaxel-industry-research-china-market
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.